Loading...
•
Dec 31, 2023
AbCellera Q4 2023 Earnings Report
Reported Q4 2023 financial results, showing a decrease in revenue compared to the previous year, but advancements in internal programs and strategic partnerships.
Key Takeaways
AbCellera reported Q4 2023 revenue of $9.2 million, representing 24% of the total revenue for 2023. The company experienced a net loss of $47.2 million, or $(0.16) per share. They advanced two internal programs into IND-enabling studies and saw three partner-initiated programs start with downstreams.
Q4 revenue was $9.2 million, 24% of total revenue for 2023.
$8.7 million was generated from research fees.
Net loss for Q4 was $47.2 million, or $(0.16) per share.
Advanced two internal programs into IND-enabling studies: ABCL635 and ABCL575.
Revenue by Segment
Forward Guidance
AbCellera is shifting capital allocation from building capabilities to using them, which includes advancement of our first internal programs and strategic partnerships.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...